In vivo, severe COVID-19 patients, including children who experience a Kawasaki-like, multi-system inflammatory syndrome in response to the virus have reduced expression of HLA-DR and CD86 in cDC [66,67]. The gene discussed is CD86; the disease is COVID-19.